Physician profile
Paul G Mitchell
NPI 1912909813
$2,290.14
in general payments reported to CMS, 2019-2025
12 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $12.81 · 2021: $103 · 2022: $213 · 2023: $157 · 2024: $181 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378 · Travel and Lodging: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.21 |
| Travel and Lodging | $269.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,172.95 | 2019-2023 | Argos, Clareon |
| Orthofix Medical, INC. | $269.00 | 2025 | Miscellaneous |
| Bausch & Lomb Americas INC. | $222.58 | 2022-2024 | Envista Mx60 Iol, Miebo, Envista Aspire Iol |
| Eyepoint US, INC. | $125.00 | 2019 | |
| Rxsight INC | $124.95 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $120.61 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $72.33 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $71.78 | 2019-2021 | |
| Inspire Medical Systems, INC. | $40.07 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $37.07 | 2019-2021 | |
| Shire North American Group INC | $21.79 | 2019 | |
| Ocular Therapeutix, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.